Bourse Actualite Stock
Lyrics Songs Paroles Video



Bourse FRANCE
SRD
EUROLIST A
EUROLIST B
EUROLIST C
Marche Libre
CAC 40
SBF 120
SBF 250
MIDCAC
Bourse EUROPE
Bourse Allemagne
Bourse Angleterre
Bourse Autriche
Bourse Belgique
Bourse Danemark
Bourse Espagne
Bourse Finlande
Bourse Grece
Bourse Islande
Bourse Luxembourg
Bourse Italie
Bourse Norvege
Bourse Pologne
Bourse Portugal
Bourse Pays-Bas
Bourse Suede
Bourse Suisse

Bourse Europe Est


 
Accueil
Google
Recherche WWW Recherche sur Ernstrade.com

Agennix AG
Exchanges: Frankfurt

Agennix AG is a publicly traded biopharmaceutical company focused on developing novel anti-cancer therapies.  The Company was formed by the combination of GPC Biotech AG and Agennix Incorporated.  The Company’s most advanced program is talactoferrin, an oral targeted therapy that is in Phase 3 clinical trials in non-small cell lung cancer. Other clinical development programs include RGB-286638, a multi-targeted kinase inhibitor in Phase 1 testing; the oral platinum-based compound satraplatin; and a topical gel form of talactoferrin for wound healing.  Agennix is a transatlantic company with sites in Munich, Germany; Princeton, New Jersey and Houston, Texas.
 

http://www.agennix.com
 

 

Copyright  2009 Ernstrade.com

Bourse ETATS UNIS
Bourse NASDAQ
Bourse NYSE
Bourse ASE
Bourse Philadelphia
Bourse Boston
Bourse AMERIQUES
Bourse Bresil
Bourse Canada
Bourse Jamaique
Bourse Trinidade


Avertissement légal - Contact Webmaster - Partenaires